Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Great Tree Pharmacy CoROCO:6469 +0.64%70 EV-to-FCF is 20.81 as of Jul. 13, 2026, which is 36% below its 10-year median of 32.32. GuruFocus rates ROCO:6469 with a GF Score™ of 70/100 and a GF Value™ of NT$193.70 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 403 Healthcare Providers & Services companies, Great Tree Pharmacy Co ranks worse than 58.06% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Great Tree Pharmacy Co's Enterprise Value is NT$16,380 Mil.
Great Tree Pharmacy Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$787 Mil. Therefore, Great Tree Pharmacy Co's EV-to-FCF for today is 20.81.
The historical rank and industry rank for Great Tree Pharmacy Co's EV-to-FCF or its related term are showing as below:
ROCO:6469'
s EV-to-FCF Range Over the Past 10 Years
Min: -2468.75 Med: 32.32 Max: 978.37
Current: 20.72
During the past 13 years, the highest EV-to-FCF of Great Tree Pharmacy Co was 978.37. The lowest was -2468.75. And the median was 32.32.
ROCO:6469's EV-to-FCF is ranked worse than 58.06% of 403
companies
in the Healthcare Providers & Services industry
Industry Median: 18.07
vs ROCO:6469: 20.72
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Great Tree Pharmacy Co (ROCO:6469) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Great Tree Pharmacy Co's PE Ratio (TTM) for today is calculated as:
Great Tree Pharmacy Co's share price for today is NT$78.50.
Great Tree Pharmacy Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$3.897.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Great Tree Pharmacy Co EV-to-FCF Competitor Comparison
For the Pharmaceutical Retailers subindustry, Great Tree Pharmacy Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Great Tree Pharmacy Co EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Great Tree Pharmacy Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Great Tree Pharmacy Co's EV-to-FCF falls into.
Great Tree Pharmacy Co's current Enterprise Value is NT$16,380 Mil.
Great Tree Pharmacy Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$787 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Great Tree Pharmacy Co (ROCO:6469) has a EV-to-FCF of 20.81 as of Jul. 13, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Great Tree Pharmacy Co and its competitors. This is 36% below median its historical median of 32.32. According to the industry distribution chart, Great Tree Pharmacy Co ranks #234 out of 403 companies in the Healthcare Providers & Services industry, placing it in the top 58.1%.
Is Great Tree Pharmacy Co's EV-to-FCF too high?
Great Tree Pharmacy Co's current EV-to-FCF of 20.81 is 36% below median its 10-year median of 32.32. The Healthcare Providers & Services industry median EV-to-FCF is 18.07. Great Tree Pharmacy Co's value of 20.81 is 15.2% above this industry median. Based on the distribution chart, Great Tree Pharmacy Co ranks #234 out of 403 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Great Tree Pharmacy Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Great Tree Pharmacy Co's EV-to-FCF compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Great Tree Pharmacy Co ranks #234 out of 403 companies for EV-to-FCF. This places Great Tree Pharmacy Co in the lower half of its industry. The industry median EV-to-FCF is 18.07. Great Tree Pharmacy Co's value of 20.81 is 15.2% above this benchmark. While the company's 10-year median is 32.32 vs. the industry median of 18.07, Great Tree Pharmacy Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.07, based on 403 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Great Tree Pharmacy Co's current EV-to-FCF of 20.81 is 15.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Great Tree Pharmacy Co and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Great Tree Pharmacy Co's current EV-to-FCF is 20.81, which is 36% below median its own 10-year median of 32.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Great Tree Pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Great Tree Pharmacy Co (ROCO:6469) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$193.70, compared to a current price of NT$78.50 — trading 59.5% below its estimated fair value. The current EV-to-FCF is 20.81, which is 36% below median its 10-year median of 32.32 and 15.2% above the Healthcare Providers & Services industry median of 18.07. Great Tree Pharmacy Co's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Great Tree Pharmacy Co (ROCO:6469), the current EV-to-FCF is 20.81 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Great Tree Pharmacy Co (ROCO:6469) Overvalued in 2026?
Based on GuruFocus' analysis, Great Tree Pharmacy Co stock appears to be undervalued.
The current stock price of NT$78.50 is trading 59.5% below its estimated GF Value™ of NT$193.70.
GuruFocus considers Great Tree Pharmacy Co to be Significantly Undervalued.
Key valuation signals for ROCO:6469:
EV-to-FCF: 20.81 (36% below median its 10-year median of 32.32)
GF Value™: NT$193.70 vs. price of NT$78.50 (59.5% below fair value)
Industry Position: 15.2% above the Healthcare Providers & Services median (#234 of 403)
No single metric tells the full story. See the ROCO:6469 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Great Tree Pharmacy Co Ltd engages in management and trading of various drugs, health supplements, maternity and infant products, and cosmetics products. It also provides coordinated medicine procurement services to various clinics, outpatient centers, and medical communities. Besides, it is also an agency for domestic and foreign health care products sold in clinics, outpatient centers, and medical communities. Its products include infant formula, baby diapers, Maternal and Infant Related, Adult drinks, Nutrition and health care, Body care, Daily Necessities, medical equipment, and Pet products.
70GF Score
Get the complete analysis for ROCO:6469
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6469 has been successfully added to your 
